Advertisement
Journal Home
Search for

Volume 197, Issue 3, Supplement, Pages S10-S16 (September 2007)


View previous. 4 of 20 View next.

Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States

Matthew T. McKenna, MD, MPH12Corresponding Author Informationemail address, Xiaohong Hu, MS2

Received 14 December 2006; accepted 26 February 2007.

We analyzed national surveillance data that had been reported to the Centers for Disease Control and Prevention to elucidate the impact of recent clinical and public health efforts to further decrease the number of human immunodeficiency virus (HIV) infections and resulting morbidity caused by perinatal transmission. Long-term trends in pediatric (ages, 0-13 years), perinatal acquired immune deficiency syndrome (AIDS) cases were analyzed by log-linear Poisson regression for the period 1992-2004. Estimates for the number of perinatal HIV infections that occurred during the more recent period of 2001-2004 were developed by extrapolation from the 33 states with ongoing HIV (non-AIDS) reporting to the entire United States with the use of a probabilistic model. The number of pediatric perinatal AIDS cases that were identified decreased from 858 in 1992 to only 41 in 2004. These declines were consistent across demographic and regional subgroups. Data on the number of perinatal HIV infections suggests ongoing declines throughout the early years of the 21st century from 277 (95% CI, 224-346) in 2001 to 138 (95% CI, 96-186) in 2004. The incidence and morbidity associated with perinatal HIV infection continue to decline. To ensure that existing prevention efforts continue to achieve control of these infections, consistent methods of public health surveillance must be instituted throughout the entire United States.

1 Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA

2 Northrop Grumman Information Technology, CDC Information Technology Support, Atlanta GA.

Corresponding Author InformationReprints: Matthew T. McKenna, MD, MPH, Centers for Disease Control and Prevention, Chief, HIV Incidence and Case Surveillance Branch, 1600 Clifton Road, MS E-47, Atlanta, GA 30333

 The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.

PII: S0002-9378(07)00268-2

doi:10.1016/j.ajog.2007.02.032


View previous. 4 of 20 View next.

Advertisement